Mamoru Narukawa

8PUBLICATIONS
5CO-AUTHORS
Characterisation of biological macromoleculesHealth and ecological risk assessmentMolecular targetsPharmacogenomicsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 30, 2026
Composite Endpoints in Contemporary Cardiovascular Trials: Trends in Phase 3 Trials and Key Issues in Regulatory Review.

|May 05, 2026
Comparative Analysis of Additional Risk Minimization Measures in the Risk Management Plan in the European Union and Japan.

|Mar 18, 2026
Strategic Integration of Companion Diagnostics in Precision Oncology: Key Factors, Drug Development Timelines, and Regulatory Insights from U.S. FDA Approvals.

Kaku Saito, Mamoru Narukawa

|Jul 12, 2025
Drug Loss in Japan: A Comparative Analysis with Europe for New Drugs Developed by Emerging Biopharma Companies.

Mihoko Kobayashi, Mamoru Narukawa

|Feb 19, 2025
Bridging Gaps in Oncology: Comparative Analysis of Development and Approval Pathways for Anticancer Drugs and Companion Diagnostic in the United States and Japan.

Kaku Saito, Mamoru Narukawa

|Dec 09, 2024
Background Factors Contributing to Safety Warning Discordance in the Initial Labeling of New Drugs in Japan, the United States, and the European Union.

Koichi Fukuda, Mamoru Narukawa

Pageof 2

Frequent Collaborators

2 joint publications

Mihoko Kobayashi

2 joint publications

Kaku Saito

1 joint publications

Koichi Fukuda

1 joint publications

Teruyuki Honda